After gaining approval from the U.S. Food and Drug Administration (F.D.A.) in March, Juvéderm’s latest injectable, Vollure™ XC is currently joining an ever-expanding list of hyaluronic acid fillers at your doctor’s office. And we, for one, are pretty excited about it.
Why? Because Allergan, who owns some of the biggest names in injectables such as Botox, Kybella and Juvéderm, claims that Vollure lasts for up to 18 months – and that’s a whole lot longer than most injectables currently on the market. Ooh, now things are getting interesting…
But let’s take a few steps back. Formulated to tackle ‘moderate to severe facial wrinkles and folds such as nasolabial folds’ in adults over 21, Vollure is all about dealing with laughter lines in a super-effective but totally natural-looking fashion. It does this by harnessing a special Vycross technology which has the ability to bind different molecular-weights of hyaluronic acid (HA).
So what, we hear you ask? Well, this is important because it helps to create a more malleable, gel-like substance that can be molded to lift sunken skin and fill in fine lines, while maintaining enough movement to work with your facial expressions. Yes, that means buh-hye frozen face syndrome. Group hugs all round.
More good news is this new formula results in very little swelling post-procedure, and not only that but visible results may last for up to a year longer than other dermal fillers, giving you a much shorter recovery time and making it a helluva lot better value for money.
So, that’ll be why Juvéderm is the number-one selling collection of dermal filler products in the U.S., then. Bring it…
Written by: Georgia Gould